Antidepressants Flashcards
(39 cards)
Antidepressant Targets
- TCAs inhibit the reuptake of NE and 5-HT
- SSRIs selectively inhibit the reuptake of 5-HT
- SNRIs inhibit the reuptake of NE and 5-HT
- DA reuptake inhibitors - Bupropion
- MAOIs inhibit the metabolism of NE, DA, and 5-HT
Tricyclic Antidepressants (TCA) - MoA
Inhibit re-uptake of NE and 5-HT Also block a-adrenergic, histamine and muscarinic receptors No euphoria/low abuse potential 2-4 weeks to have effect
Tricyclic Antidepressants (TCA) - Uses
depression
- chronic pain (TMJ), fibromyalgia
- enuresis
TCAs
Amitriptyline (Elavil®)
Imipramine (Tofranil®)
Nortriptyline (Pamelor®)
Desipramine (Norpramin®)
Amitriptyline (Elavil®); Imipramine (Tofranil®)
- Tertiary amines
- Primary inhibit 5-HT re-uptake
- Produce more seizures than secondary amines
- More sedating than secondary amines
Nortriptyline (Pamelor®); Desipramine (Norpramin®)
- Secondary amines
* Primarily block NE re-uptake
TCA Pharmacokinetics
Well-absorbed orally
Variable and long half-lives (10-90 hrs)
They are generally given once a day, at bedtime.
Metabolized by CYP2D6 - drug interactions VERY
common
TCA Side Effects
Weight gain
Histamine receptor blockade
• Drowsiness, fatigue, sedation
Cholinergic blockade
• Blurred vision, tachycardia, constipation, urinary
retention, dry mouth, palpitations
• Impairment of memory and cognition
alpha1 receptor blockade
• Cardiac depression and arrhythmias
• Postural hypotension, dizziness, reflex tachycardia
Analgesia results from activation of descending
noradrenergic pathways in the spinal cord (NE acts on
α2receptors to decrease glutamate input into pain
pathway going to brain)
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) may occur. This may lead to water intoxication and hyponatremia.
Sexual dysfunction
Decrease in seizure threshold
Tolerance generally develops to sedation, postural
hypotension and to the anticholinergic effects
Can be used in pregnancy
TCA Toxicity and Overdose
Cardiac Toxicity Torsadesde pointes prolongedQT interval cardiac arrhythmias severe hypotension agitation, delirium seizures, hyperpyrexia coma, shock, metabolic acidosis respiratory depression
Treatment of TCA overdose
Cardiac monitoring, supportive care
Gastric lavage and activated charcoal
Magnesium, isoproterenol and cardiac pacing for
Torsadesde pointes
Lidocaine, propranolol, phenytoin to manage
arrhythmias and/or prevent seizures
Sodium bicarbonate and potassium chloride to
restore acid/base balance
TCA Drug Interactions
Combined with MAOIs can result in serotonin
syndrome: severe CNS toxicity manifested by
hyperpyrexia, convulsions and coma
TCAs compete for metabolism of SSRIs, thus
combination can lead to toxic levels of TCAs
TCAs may cause hypertension when combined with
sympathomimetic drugs such as amphetamine
TCAs potentiate the sedative actions of alcohol/CNS
depressants
TCAs potentiate the effects of anticholinergic drugs
Selective Serotonin Reuptake Inhibitors (SSRIs)
Fluoxetine (Prozac®) Sertraline (Zoloft®) Paroxetine (Paxil®) Citalopram (Celexa®) Escitalopram (Lexapro®)
Selective Serotonin Reuptake Inhibitors (SSRIs) - Uses
- Depression
- Panic disorder
- Obsessive-compulsive disorder: Paroxetine (Paxil®)
- Social anxiety: Paroxetine (Paxil®)
- Bulimia
- Alcoholism
- Children and Teenagers
Fluoxetine (Prozac®)
• Half-life of 2-3 days; Norfluoxetine, active metabolite,
7-9 days
• Most likely to inhibit CYP450 enzymes (CYP2D6)
• More drug interactions than other SSRIs
• Impairs blood glucose levels in diabetics
Sertraline (Zoloft®)
- Half life of 26 hours; Extensive first-pass elimination
- Least likely SSRI to interact with other drugs
- Preferred in elderly
Citalopram (Celexa®) / Escitalopram (Lexapro®)
• Currently the DOC for depression
• Low incidence of pharmacokinetic interactions and
side effects
Selective Serotonin Reuptake Inhibitors (SSRIs) - MoA
- Selectively inhibits 5-HT reuptake
* 2-3 weeks to be effective
Selective Serotonin Reuptake Inhibitors (SSRIs) - Pharmacokinetics
- Well absorbed by gut
- Half life = 24-72 hours
- Metabolized by CYP450s (2D6)
- Inhibit CYP450s
- Many drug interactions
SSRI Side Effects
Mild side effects; Less autonomic side effects and
chance for cardiac arrhythmias than TCAs
GI: nausea, loss of appetite, constipation
Weight loss or gain possible
CNS stimulation (anxiety or insomnia) may occur with
fluoxetine or sertraline
Sedation more likely with other drugs
Sexual disinterest/dysfunction, impairment of
ejaculation
Photosensitivity, limit sun exposure
SSRI Drug Interactions
Inhibition of CYP3A4 and CYP2D6
• TCAs: Inhibition of metabolism increases toxicity
• Phenytoin and carbamazepine: increased levels and
toxicity
MAOIs: Serotonin syndrome
St. John’s Wort or amphetamines - serotonin
syndrome
beta-blockers: may result in heart block and
hypotension
Opioids
• Codeine - Fluoxetine inhibits conversion to the
active compound
• Meperidine - Increases 5-HT; potential for serotonin
syndrome
• Tramadol - Increased risk of seizures
Serotonin-norepinephrine reuptake inhibitors (SNRI)
SNRIs inhibit NE & 5-HT re-uptake
More side effects than SSRIs
Uses: depression, neuropathic pain, post
menopausal hot flashes
Venlafaxine (Effexor®)
• May increase blood pressure
Duloxetine (Cymbalta®)
• May cause hepatotoxicity
• May cause bilateral acute angle-closure glaucoma
(ACG)
Monoamine Oxidase Inhibitors (MAOIs)
Irreversibly inhibit MAOs which metabolize NE, DA and 5-HT
Phenelzine (Nardil®)
Selegiline (Deprenyl®)
Phenelzine (Nardil®)
Inhibits both MAO-A and MAO-B
- Increases NE and 5-HT (and DA)
- Actions persist longer than serum levels
- Also a substrate for MAOs
- Depression that hasn’t responded to other drugs
- Drug of last choice - serious side effects
Selegiline (Deprenyl®)
Selectively inhibits MAO-B
- Increases DA
- Fewer side effects
- Also used in Parkinson’s